ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ZVSA ZyVersa Therapeutics Inc

0.0758
-0.0044 (-5.49%)
Pre Market
Last Updated: 21:10:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ZyVersa Therapeutics Inc ZVSA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0044 -5.49% 0.0758 21:10:01
Open Price Low Price High Price Close Price Previous Close
0.0802
more quote information »

Recent News

Date Time Source Heading
21/11/202309:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/11/202308:15EDGAR2Form 8-K - Current report
15/11/202308:35GLOBEZyVersa Therapeutics Reports Third Quarter 2023 Corporate..
09/11/202323:35GLOBEZyVersa Therapeutics Announces Article Published in..
06/11/202323:05GLOBEZyVersa Therapeutics Announces Article in Peer-Reviewed..
03/11/202307:37EDGAR2Form 8-K - Current report
01/11/202323:07GLOBEZyVersa Therapeutics Announces Publication in Molecular..
25/10/202321:50GLOBEZyVersa Therapeutics Announces Research Published in the..
25/10/202307:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202315:15EDGAR2Form EFFECT - Notice of Effectiveness
18/10/202322:05GLOBEZyVersa Therapeutics Announces a Publication in the..
18/10/202307:15EDGAR2Form S-1/A - General form for registration of securities..
11/10/202322:05GLOBEZyVersa Therapeutics Announces Peer-Reviewed Publication in..
04/10/202322:05GLOBEZyVersa Therapeutics Announces New Peer-Reviewed Publication..
27/9/202321:07GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover to Participate..
22/9/202320:35GLOBEZyVersa Therapeutics Announces Research Published in The..
21/9/202307:15EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202321:00EDGAR2Form 8-K - Current report
14/9/202306:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202306:40EDGAR2Form DEF 14A - Other definitive proxy statements
12/9/202320:30GLOBEZyVersa Therapeutics Announces Research Published in..
09/9/202306:20EDGAR2Form 8-K - Current report
02/9/202306:45EDGAR2Form PRE 14A - Other preliminary proxy statements
22/8/202306:15GLOBEZyVersa Therapeutics Reports Second Quarter 2023 Corporate..
22/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/8/202306:13EDGAR2Form 8-K - Current report
15/8/202322:26EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
03/8/202321:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202307:27EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/7/202307:11EDGAR2Form 8-K - Current report
27/7/202306:21EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
24/7/202322:00GLOBEZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million..
17/7/202321:38GLOBEZyVersa Therapeutics Announces Publication in the Journal,..
14/7/202321:37GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited..
10/7/202321:37GLOBEZyVersa Therapeutics Announces Publication in the Journal..
08/7/202305:44EDGAR2Form S-1/A - General form for registration of securities..
07/7/202321:37GLOBEEuropean Patent Granted for ZyVersa Therapeutics' Lead..
01/7/202307:01EDGAR2Form S-1/A - General form for registration of securities..
28/6/202321:37GLOBEZyVersa Therapeutics Announces Publication in Clinical..
21/6/202306:07GLOBEZyVersa Therapeutics Announces a Publication in Journal of..
13/6/202322:07GLOBEZyVersa Therapeutics Publishes New White Paper Detailing the..
06/6/202323:07GLOBEEuropean Patent Office to Grant ZyVersa Therapeutics’ Patent..
25/5/202323:07GLOBEZyVersa Therapeutics Announces a Publication in Frontiers in..
20/5/202306:15GLOBEZyVersa Therapeutics Announces Changes to ZyVersa’s Board of..
15/5/202323:07GLOBEZyVersa Therapeutics Announces Article Published in..
12/5/202323:07GLOBEZyVersa Therapeutics Reports First Quarter 2023 Corporate..
11/5/202323:07GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate..
09/5/202323:05GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate..
04/5/202323:07GLOBEZyVersa Therapeutics Announces a Publication in Hepatology..
02/5/202308:30GLOBEZyVersa Therapeutics, Inc. Announces Closing of $11.0..

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com